Schedule 13G ownership disclosure

Phathom Pharmaceuticals Inc

Security class unavailable · CUSIP: 71722W107

Event date: 2023-03-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-066126
Form type
SC 13G
Filer
Carlyle Group Inc.
CIK
CIK 1527166
Filed
Mar 09, 2023
Reporting period
Mar 01, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub